Skip to main content
. 2007 Dec 11;93(3):944–950. doi: 10.1210/jc.2007-1388

Figure 2.

Figure 2

Mean GH concentrations monitored every 10 min over 2.5 h during and after iv infusion of GHRH/GHRP-2 (top), L-arginine/GHRP-2 (middle), and L-arginine/GHRH (bottom). Bolus peptide injections were given at 30 min. Data are the mean ± sem (n = 12 eugonadal and n = 10 hypogonadal men).

HHS Vulnerability Disclosure